Sec Form 4 Filing - HERON ELAINE J @ BIOMARIN PHARMACEUTICAL INC - 2012-11-07

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
HERON ELAINE J
2. Issuer Name and Ticker or Trading Symbol
BIOMARIN PHARMACEUTICAL INC [ BMRN]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X __ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle)
C/O BIOMARIN PHARMACEUTICAL INC., 105 DIGITAL DRIVE
3. Date of Earliest Transaction (MM/DD/YY)
11/07/2012
(Street)
NOVATO, CA94949
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/07/2012 11/07/2012 M 30,000 A $ 7.46 75,900 D
Common Stock 11/07/2012 11/07/2012 M 30,000 A $ 14.93 105,900 D
Common Stock 11/07/2012 11/07/2012 M 15,000 A $ 17.33 120,900 D
Common Stock 11/07/2012 11/07/2012 M 15,000 A $ 38.59 135,900 D
Common Stock 11/07/2012 11/07/2012 M 15,000 A $ 14.39 150,900 D
Common Stock 11/07/2012 11/07/2012 S 105,000 D $ 46.4392 ( 1 ) 45,900 D
Common Stock 11/09/2012 11/09/2012 S 30,000 D $ 48.0117 ( 2 ) 15,900 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) $ 7.46 11/07/2012 11/07/2012 M 30,000 10/12/2005( 3 ) 07/11/2015 Common Stock 30,000 $ 0 113,500 D
Stock Option (right to buy) Common Stock $ 14.93 11/07/2012 11/07/2012 M 30,000 10/12/2006( 4 ) 07/11/2016 Common Stock 30,000 $ 0 83,500 D
Stock Option (right to buy) Common Stock $ 17.33 11/07/2012 11/07/2012 M 15,000 09/07/2007( 5 ) 06/07/2017 Common Stock 15,000 $ 0 68,500 D
Stock Option (right to buy) Common Stock $ 38.59 11/07/2012 11/07/2012 M 15,000 08/22/2009( 6 ) 05/21/2018 Common Stock 15,000 $ 0 53,500 D
Stock Option (right to buy) Common Stock $ 14.39 11/07/2012 11/07/2012 M 15,000 08/12/2009( 7 ) 05/11/2019 Common Stock 15,000 $ 0 38,500 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
HERON ELAINE J
C/O BIOMARIN PHARMACEUTICAL INC.
105 DIGITAL DRIVE
NOVATO, CA94949
X
Signatures
/s/ Laura Randall Woodhead, Attorney-in-Fact 11/09/2012
Signature of Reporting Person Date
Explanation of Responses:
( 1 )The price in Column 4 is a weighted average price. The prices actually received ranged from $46.285 to $46.64. The reporting person will provide to the issue, any security holder of the issuer, or SEC staff, upon request, information regarding the number of shares sold at each price within the range.
( 2 )The price in Column 4 is a weighted average price. The prices actually received ranged from $47.49 to $48.56. The reporting person will provide to the issue, any security holder of the issuer, or SEC staff, upon request, information regarding the number of shares sold at each price within the range.
( 3 )Options vest 1/4th each on October 12, 2005, January 12, 2006, April 12, 2006 and July 12, 2006.
( 4 )Options vest 1/4th each on October 12, 2006, Januray 12, 2007, April 12, 2007 and July 12, 2007.
( 5 )Options vest 1/4th each on September 7, 2007, December 7, 2007, March 7, 2008 and June 7, 2008.
( 6 )Options vest 1/4th each on August 22, 2008, November 22, 2008, February 22, 2009 and May 22, 2009.
( 7 )Options vest 1/4th each on August 12, 2009, November 12, 2009, February 12, 2010 and May 12, 2010.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.